This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (670) Frailty Detection, Assessment and Prediction (59) Cancer and Clinical Trials (37) Chemotherapy and Side Effects Management (109) Doctor-Patient Communication on Cancer, Prevention, and Screening (75) Patient-Reported Outcome Measures (PROMs) (363)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/76628, first published .
Frailty Trajectories and Influencing Factors in Patients With Non-Hodgkin Lymphoma During Chemotherapy: Protocol for a Longitudinal Mixed Methods Study

Frailty Trajectories and Influencing Factors in Patients With Non-Hodgkin Lymphoma During Chemotherapy: Protocol for a Longitudinal Mixed Methods Study

Frailty Trajectories and Influencing Factors in Patients With Non-Hodgkin Lymphoma During Chemotherapy: Protocol for a Longitudinal Mixed Methods Study

Authors of this article:

Ruofei Du1 Author Orcid Image ;   Ying Zhang2 Author Orcid Image ;   Huimin Yang1, 2 Author Orcid Image ;   Yating Du2 Author Orcid Image ;   Jin Li1 Author Orcid Image ;   Bingyan Zhang3 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Ruofei Du   1 * , MSc, PhD ;   Ying Zhang   2 * , MSc ;   Huimin Yang   1, 2 , BS ;   Yating Du   2 , MSc ;   Jin Li   1 , MSc ;   Bingyan Zhang   3 , MSc

1 Lymphoma Ward, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China

2 Department of Nursing, Henan University of Science and Technology, Luoyang, China

3 Department of Nursing, Luoyang Maternal and Child Health Hospital, Luoyang, China

*these authors contributed equally

Corresponding Author:

  • Huimin Yang, BS
  • Lymphoma Ward, The First Affiliated Hospital of Henan University of Science and Technology
  • No. 24 Jinghua Road, Jianxi District
  • Luoyang 471000
  • China
  • Phone: 86 18837950376
  • Email: Yhm2011512@163.com